Research, published by the Social Science Research Network, found Covid-19 patients given doses of Vitamin D were 80 per cent less likely to require ICU treatment.
Those from the University of Barcelona also concluded that ‘adjusted results showed a reduced mortality of more than 60 per cent’ for those who were given the calcifediol treatment.
The study evaluated the effectiveness of calcifediol – a Vitamin D3 – on more than 550 people admitted to the Covid-19 wards of the Hospital del Mar in Barcelona, Spain.
Subjects were randomly assigned as either recipients of the calcifediol treatment or as controls on admission, before receiving five doses of the vitamin in increasing intervals of two, four, eight and 15 days.